Channel August 23, 2021 Refined Channel Data: Unblinding 3 Minute Read Unblinding national datasets gives Life Sciences manufacturers a clear view into where and when their therapies are being utilized.
Contracts & Pricing August 13, 2021 Compliance Guidelines for Government Programs 5 Minute Read Six key elements to operate an effective compliance program. Also, new VA FSS rules for vaccine drugs, State Price Transparency, and Medicare Part D updates and reminders.
Contracts & Pricing July 26, 2021 The Branded Pharma Fee Deadline Approaches 4 Minute Read We'll tell you how to prepare. Plus new manufacturer awareness for orphan drugs, midnight changes to MDRP, and upholding the ACA.
ICyte Platform July 8, 2021 Breaking down the Silos for Next-Generation Access 5 Minute Read This blog is the fourth in a series that shares our vision for future-proofing Market Access. Manufacturers can evolve the Market Access function to work toward their commercial, financial, and...
Patient Access July 1, 2021 Frequently Asked Questions – Data Aggregation 3.0 3 Minute Read As channels evolve with a shift toward precision medicines, larger patient access obstacles have emerged, and new approaches are needed to transform the world of data aggregation.
Contracts & Pricing June 29, 2021 SPTR, CMS Final Rule & VA Public Law Updates 5 Minute Read The latest regulatory updates and reporting reminders for June 2021.
ICyte Platform June 17, 2021 Operational Goals to Future Proof Market Access 3 Minute Read In this third installment, we look at operational goals for Market Access. Commercial Operations and Contracting teams need a flexible infrastructure that can support business scale and the changing...
Patient Access June 14, 2021 Frequently Asked Questions – Patient Tokenization 3 Minute Read Patient tokenization is one of the most mysterious, least understood, and most essential technologies behind actionable patient data. Taken from the Q&A session of IntegriChain's recent Patient Tokenization webinar....
ICyte Platform June 3, 2021 Financial Goals to Future Proof Market Access 3 Minute Read In this four-part series, we examine the key goals of Market Access teams as they look to the future with the advent of speciality and precision medicine and how...
